Bottom line
PHSRX vs RYHIX: the short answer
PHSRX (Putnam Global Health Care Fund) and RYHIX (Health Care Fund) are both mutual funds.
PHSRX is cheaper at 1.29% vs 1.38% — a difference of $9.00 a year per $10,000 invested.
Over five years, PHSRX returned +7.5% a year vs +5.1% for RYHIX (reporting dates differ).
Updated Nov 19, 2026
PHSRX vs RYHIX side by side
| PHSRX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.29% | 1.38% |
| Annual cost per $10k | $129 | $138 |
| 10-yr cost on $10k (prospectus) | $1,556 | $1,709 |
| Max front load | 0% | — |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +1.0% | +14.4% |
| 5-yr return (annualized) | +7.5% | +5.1% |
| 10-yr return (annualized) | +7.2% | +7.9% |
| Best quarter | — | +18.7% |
| Worst quarter | — | −14.4% |
| Net assets (fund) | $1.5B | $19.4M |
| Number of holdings | 115 | 135 |
| Portfolio turnover | 67% | 244% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of PHSRX's top 25 holdings also appear in RYHIX's top 25.
| Holding | PHSRX | RYHIX |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 3.63% |
| Johnson & Johnson | 8.46% | 2.88% |
| UnitedHealth Group, Inc. | 6.93% | 2.22% |
| AbbVie, Inc. | 6.05% | 2.52% |
| Merck & Co., Inc. | 4.88% | 2.04% |
| Thermo Fisher Scientific, Inc. | 4.50% | 1.61% |
| Intuitive Surgical, Inc. | 4.04% | 1.31% |
| Edwards Lifesciences Corp. | 2.80% | 0.84% |
| CVS Health Corp. | 2.74% | 1.31% |
| Gilead Sciences, Inc. | 2.63% | 1.39% |
| McKesson Corp. | 2.14% | 1.05% |
| Cardinal Health, Inc. | 2.12% | 0.86% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 1.34% |
| Boston Scientific Corp. | 1.80% | 0.86% |
| Bristol-Myers Squibb Co. | 1.75% | 1.22% |
Source: SEC Form N-PORT
PHSRX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between PHSRX and RYHIX?
PHSRX (Putnam Global Health Care Fund) and RYHIX (Health Care Fund) are both mutual funds. PHSRX is cheaper at 1.29% vs 1.38% — a difference of $9.00 a year per $10,000 invested.
Which is cheaper, PHSRX or RYHIX?
PHSRX has the lower expense ratio (1.29%).
Should I own both PHSRX and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.